Article info

Download PDFPDF

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis
Free
  1. Correspondence to: Ina Kötter, MD, Department of Internal Medicine II, (Hematology/Oncology/Immunology/Rheumatology) University Hospital, Otfried-Müller Strasse 10, D-72076 Tübingen, Germany; ina.koetter{at}med.uni-tuebingen.de
View Full Text

Citation

Kötter I, Zierhut M, Eckstein AK, et al
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Publication history

  • Accepted October 14, 2002
  • First published April 1, 2003.
Online issue publication 
April 01, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.